Back
Fate Therapeutics Vs. iBio Industry Stock Comparison
Sell
34
FATE
Fate Therapeutics
Last Price:
2.81
Seasonality Move:
31.52%
Sell
47
IBIO
iBio
Last Price:
2.78
Seasonality Move:
-25.98%
Sell
34
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.03. The Score for FATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
iBio (IBIO)
is a Sell
Is iBio a Buy, Sell or Hold?
- The current iBio [IBIO] share price is $2.73. The Score for IBIO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- IBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.
IBIO Stock Price Chart
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 39.11 | Sell |
| Chaikin Money Flow: | -751726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.03 - 3.61) | Sell |
| Bollinger Bands (100): | (3.13 - 4.31) | Sell |
IBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 58.1 | Buy |
| Chaikin Money Flow: | -47039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.99 - 2.79) | Buy |
| Bollinger Bands (100): | (1.84 - 2.46) | Buy |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.13 | Sell |
| 20-day SMA: | 3.2 | Sell |
| 50-day SMA: | 3.48 | Sell |
| 200-day SMA: | 4.69 | Sell |
| 8-day EMA: | 3.13 | Sell |
| 20-day EMA: | 3.23 | Sell |
| 50-day EMA: | 3.48 | Sell |
| 200-day EMA: | 4.29 | Sell |
IBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.81 | Sell |
| 20-day SMA: | 2.52 | Buy |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 1.88 | Buy |
| 8-day EMA: | 2.79 | Sell |
| 20-day EMA: | 2.57 | Buy |
| 50-day EMA: | 2.3 | Buy |
| 200-day EMA: | 4.21 | Sell |
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.03 per share.
iBio Earnings Growth & IBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.
Fate Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iBio Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||